Jointown Pharmaceutical Group Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 0.08%

Jointown Pharmaceutical Group Co Ltd (600998) has an Asset Resilience Ratio of 0.08% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Jointown Pharmaceutical Group Co Ltd carry for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥84.52 Million
≈ $12.37 Million USD Cash + Short-term Investments

Total Assets

CN¥112.28 Billion
≈ $16.43 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2012–2024)

This chart shows how Jointown Pharmaceutical Group Co Ltd's Asset Resilience Ratio has changed over time. See Jointown Pharmaceutical Group Co Ltd net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Jointown Pharmaceutical Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 600998 market cap.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥84.52 Million 0.08%
Total Liquid Assets CN¥84.52 Million 0.08%

Asset Resilience Insights

  • Limited Liquidity: Jointown Pharmaceutical Group Co Ltd maintains only 0.08% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Jointown Pharmaceutical Group Co Ltd Industry Peers by Asset Resilience Ratio

Compare Jointown Pharmaceutical Group Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Guangxi Liuzhou Pharm Co Ltd
SHG:603368
Medical Distribution 1.77%
Sigma Healthcare Ltd
AU:SIG
Medical Distribution 0.03%
Ebos Group Ltd
AU:EBO
Medical Distribution 0.00%
Paragon Care Ltd
AU:PGC
Medical Distribution 0.00%
Mayne Pharma Group Ltd
AU:MYX
Medical Distribution 4.00%
Cyclopharm Ltd
AU:CYC
Medical Distribution 1.98%
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
Medical Distribution 4.48%
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
Medical Distribution 4.44%

Annual Asset Resilience Ratio for Jointown Pharmaceutical Group Co Ltd (2012–2024)

The table below shows the annual Asset Resilience Ratio data for Jointown Pharmaceutical Group Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.95% CN¥972.34 Million
≈ $142.28 Million
CN¥102.40 Billion
≈ $14.98 Billion
+0.85pp
2023-12-31 0.10% CN¥90.03 Million
≈ $13.17 Million
CN¥92.79 Billion
≈ $13.58 Billion
-0.25pp
2022-12-31 0.35% CN¥319.72 Million
≈ $46.78 Million
CN¥92.27 Billion
≈ $13.50 Billion
-3.84pp
2021-12-31 4.19% CN¥3.60 Billion
≈ $526.38 Million
CN¥85.94 Billion
≈ $12.58 Billion
+4.17pp
2020-12-31 0.02% CN¥15.31 Million
≈ $2.24 Million
CN¥80.82 Billion
≈ $11.83 Billion
+0.02pp
2018-12-31 0.00% CN¥967.43K
≈ $141.57K
CN¥66.67 Billion
≈ $9.76 Billion
-0.02pp
2016-12-31 0.02% CN¥7.03 Million
≈ $1.03 Million
CN¥38.73 Billion
≈ $5.67 Billion
0.00pp
2013-12-31 0.02% CN¥3.99 Million
≈ $584.42K
CN¥18.60 Billion
≈ $2.72 Billion
-0.03pp
2012-12-31 0.05% CN¥8.04 Million
≈ $1.18 Million
CN¥14.80 Billion
≈ $2.17 Billion
--
pp = percentage points

About Jointown Pharmaceutical Group Co Ltd

SHG:600998 China Medical Distribution
Market Cap
$3.81 Billion
CN¥26.07 Billion CNY
Market Cap Rank
#4268 Global
#749 in China
Share Price
CN¥5.17
Change (1 day)
-0.39%
52-Week Range
CN¥4.85 - CN¥5.60
All Time High
CN¥44.36
About

Jointown Pharmaceutical Group Co., Ltd engages in pharmaceutical distribution and supply chain business in China and internationally. It is also involved in general agency brand promotion; pharmaceutical industrial self-production and OEM; and pharmaceutical new retail and ten-thousand store alliance plan businesses. In addition, the company provides medical health and technology value-added serv… Read more